KVUE:NYSE
Kenvue Inc
18,01 $
arrow_upward
+1,41%(+0,25) 1D
18,32 $
arrow_upward
+1,72% (+0,31)todayPre-market
Closed: 14 қаз., 16:00:05 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KVUE...
Open
17,92 $
High
18,04 $
Low
17,76 $
Mkt. cap
34,59 млрд
Avg. vol.
24,20 млн
Volume
52,52 мың
Dividend
4,66%
Quarterly dividend
0,21 $
Ex-dividend date
2026 ж. 21 қыр.
P/E ratio
20,88
52-wk high
20,13 $
52-wk low
14,02 $
EPS
0,86 $
Beta
0,48
Shares outstanding
1,92 млрд
No. of employees
22 мың
Open
17,92 $
High
18,04 $
Low
17,76 $
Mkt. cap
34,59 млрд
Avg. vol.
24,20 млн
Volume
52,52 мың
Dividend
4,66%
Quarterly dividend
0,21 $
Ex-dividend date
2026 ж. 21 қыр.
P/E ratio
20,88
52-wk high
20,13 $
52-wk low
14,02 $
EPS
0,86 $
Beta
0,48
Shares outstanding
1,92 млрд
No. of employees
22 мың
News stories
From web sources and news partners
News Corp
·
15 сағат бұрын
Kenvue Inc. stock rises Wednesday, outperforms market
Reuters
·
1 күн бұрын
EU approves Kimberly-Clark's $40 billion Kenvue acquisition
News Corp
·
1 күн бұрын
Kimberly-Clark, Kenvue Win Conditional EU Approval for $40 Billion Tie-Up
Profile
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index.
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Wikipedia
About Kenvue Inc
CEOKirk Perry
Employees21,9 мың
Founded2022
HeadquartersСаммит, Нью-Джерси, Америка Құрама Штаттары
SectorPersonal care products
Websitekenvue.com